These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Determining the extent of tumor resection at surgical planning with Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623 [TBL] [Abstract][Full Text] [Related]
4. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
5. Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466 [No Abstract] [Full Text] [Related]
6. Phase IIa clinical study of [ Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267 [TBL] [Abstract][Full Text] [Related]
12. Prospective Clinical Trial of Ulaner GA; Goldman DA; Corben A; Lyashchenko SK; Gönen M; Lewis JS; Dickler M J Nucl Med; 2017 Jul; 58(7):1037-1042. PubMed ID: 27856630 [No Abstract] [Full Text] [Related]
13. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study. Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma. Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386 [TBL] [Abstract][Full Text] [Related]
16. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas. Li DL; Xu YK; Wang QS; Wu HB; Li HS Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472 [TBL] [Abstract][Full Text] [Related]
17. Initial Experience with the Radiotracer 18F-Fluciclovine PET/CT in Ovarian Cancer. Buehner TM; Liotta M; Potkul RK; Wagner RH; Savir-Baruch B Mol Imaging Biol; 2024 Feb; 26(1):45-52. PubMed ID: 36754935 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial. Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Including Bone in Dixon-Based Attenuation Correction for Elschot M; Selnæs KM; Johansen H; Krüger-Stokke B; Bertilsson H; Bathen TF J Nucl Med; 2018 Dec; 59(12):1913-1917. PubMed ID: 29728516 [TBL] [Abstract][Full Text] [Related]